Testing effectiveness (Phase 2)Ended earlyNCT03352557What this trial is testingPhase 2 Study of BIIB092 in Participants With Early Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Biogen 654
Post-approval studies (Phase 4)Ended earlyNCT00649220What this trial is testingMemantine and Antipsychotics UseWho this might be right forAlzheimer's Disease Merz Pharmaceuticals GmbH 19
Testing effectiveness (Phase 2)Ended earlyNCT06199037What this trial is testingSafety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease PatientsWho this might be right forAlzheimer's Disease Shanghai Hengrui Pharmaceutical Co., Ltd. 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06177028What this trial is testingMCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive ImpairmentWho this might be right forCognitive Impairment, MildCognitive DysfunctionAmyloid Plaque+2 more St. Joseph's Hospital and Medical Center, Phoenix 45
Not applicableUnknownNCT04509271What this trial is testingStudy on Novel Peripheral Blood Diagnostic Biomarkers for MCI Due to Alzheimer's DiseaseWho this might be right forAlzheimer Disease Shanghai Mental Health Center 1,300
Large-scale testing (Phase 3)Study completedNCT03721705What this trial is testingRenew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's TypeWho this might be right forAlzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more Renew Research, LLC 190
Early research (Phase 1)Study completedNCT02624778What this trial is testingLY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or ADWho this might be right forAlzheimer Disease Eli Lilly and Company 61
Testing effectiveness (Phase 2)Study completedNCT00976118What this trial is testingActivity of Masitinib (AB1010) in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AB Science 34
Not applicableLooking for participantsNCT07803055What this trial is testingLongitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's DiseaseWho this might be right forSubjective Cognitive Decline (SCD)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseAlzheimer's Disease Dementia+1 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 48
Not applicableLooking for participantsNCT07667478What this trial is testingNON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASEWho this might be right forAlzheimer s DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseMild Dementia Chi-Ying (Roy) Lin 40
Large-scale testing (Phase 3)Looking for participantsNCT07170150What this trial is testingA Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseWho this might be right forAlzheimers Disease Hoffmann-La Roche 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT05399888What this trial is testingLearn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of AgeWho this might be right forMild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease Dementia Biogen 416
Not applicableLooking for participantsNCT07089303What this trial is testingAlzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)Who this might be right forAlzheimer DiseaseMild Cognitive Impairment Due to Alzheimer's Disease Chinese PLA General Hospital 750
Testing effectiveness (Phase 2)Study completedNCT01965756What this trial is testingEffect of Insulin Sensitizer Metformin on AD BiomarkersWho this might be right forAlzheimer's DiseaseVascular DementiaDementia+1 more University of Pennsylvania 20
Not applicableStudy completedNCT02414282What this trial is testingF 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)Who this might be right forAlzheimer DiseaseProgressive Posterior Cortical Dysfunction (PPCD) Tammie L. S. Benzinger, MD, PhD 20
Early research (Phase 1)Study completedNCT02094729What this trial is testingA Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Eisai Co., Ltd. 26
Not applicableLooking for participantsNCT06875986What this trial is testingREXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)Who this might be right forAlzheimer Disease Otsuka Pharmaceutical Co., Ltd. 200
Large-scale testing (Phase 3)Study completedNCT01438060What this trial is testingAripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's TypeWho this might be right forDementia, Alzheimer Type Otsuka Pharmaceutical Development & Commercialization, Inc. 232
Early research (Phase 1)Ended earlyNCT03819699What this trial is testingStudy With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to ADWho this might be right forAlzheimer Disease H. Lundbeck A/S 3
Early research (Phase 1)Study completedNCT02221622What this trial is testingAllopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild ADWho this might be right forMild Cognitive ImpairmentAlzheimer Disease University of Southern California 24